EMA Prepares To Deliver Verdict On Bevacizumab In Wet AMD

Opinion Could Be Drug's First OK For Ocular Use

Subcutaneous injection
Bevacizumab is often used off label as an intraocular injection for AMD • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

More from Geography